ITTO20000172A1 - PHYTOBIOLOGICAL DIETARY SUPPLEMENT. - Google Patents
PHYTOBIOLOGICAL DIETARY SUPPLEMENT. Download PDFInfo
- Publication number
- ITTO20000172A1 ITTO20000172A1 IT2000TO000172A ITTO20000172A ITTO20000172A1 IT TO20000172 A1 ITTO20000172 A1 IT TO20000172A1 IT 2000TO000172 A IT2000TO000172 A IT 2000TO000172A IT TO20000172 A ITTO20000172 A IT TO20000172A IT TO20000172 A1 ITTO20000172 A1 IT TO20000172A1
- Authority
- IT
- Italy
- Prior art keywords
- supplement
- supplement according
- vitamin
- extract
- total
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims description 14
- 239000013589 supplement Substances 0.000 claims description 16
- 150000003904 phospholipids Chemical class 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 9
- 244000194101 Ginkgo biloba Species 0.000 claims description 8
- 235000013311 vegetables Nutrition 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 4
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- 229960001009 acetylcarnitine Drugs 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 239000005445 natural material Substances 0.000 claims description 4
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 4
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 claims description 3
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 235000021014 blueberries Nutrition 0.000 claims description 3
- 229940055416 blueberry extract Drugs 0.000 claims description 3
- 235000019216 blueberry extract Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 3
- 239000008347 soybean phospholipid Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 208000003464 asthenopia Diseases 0.000 claims description 2
- 230000017531 blood circulation Effects 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 239000007944 soluble tablet Substances 0.000 claims description 2
- 235000019156 vitamin B Nutrition 0.000 claims description 2
- 239000011720 vitamin B Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000002490 cerebral effect Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 6
- 230000003627 anti-cholesterol Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- MOLPUWBMSBJXER-YDGSQGCISA-N Bilobalide Natural products O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930184727 ginkgolide Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001343 mnemonic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Fertilizers (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
Domanda di brevetto per invenzione industriale dal titolo: Patent application for industrial invention entitled:
Integratore dietetico fitobiologico Phytobiological dietary supplement
Campo dell'invenzione Field of the invention
La presente invenzione si riferisce ad un integratore dietetico fitobiologico a base di complesso fosfolipidico arricchito, in combinazione con altri elementi specifici che ne aumentano in modo sinergico l’attività specifica. The present invention refers to a phytobiological dietary supplement based on an enriched phospholipid complex, in combination with other specific elements that synergistically increase its specific activity.
Stato dell'arte State of the art
Gli integratori dietetici occupano un posto sempre più importante nei trattamenti di carenze psico-fisiche dovute allo stress imposto dalle attività della vita moderna nello studio, nel lavoro o nello sport. Dietary supplements occupy an increasingly important place in the treatment of psycho-physical deficiencies due to the stress imposed by the activities of modern life in study, work or sport.
Questi preparati sono quindi oggetto di studi particolari atti ad ottenere la massima efficacia da parte dei vari componenti utilizzati per la loro preparazione in modo da accentuarne gli effetti desiderati senza causare effetti collaterali negativi di alcun genere. Va infatti considerato che gran parte degli integratori sono costituiti da componenti di origine naturale le cui proprietà, pur documentate, sarebbero spesso insufficienti ad ottenere effetti sensibili e duraturi qualora questi prodotti fossero assunti da soli. Inoltre va ricordato che l’effetto finale può essere raggiunto in vari modi, cioè utilizzando principi attivi, naturali o sintetici, che svolgono azione diversa (antiossidanti, attività sulla membrana cellulare, sulle pareti dei capillari, anticolesterolo, antiaggregante piastrinico ecc.) e che interagiscono fra loro in modo più o meno sinergico per cui l’effetto finale dipende in modo determinante dal tipo di componenti che vengono miscelati. These preparations are therefore the subject of particular studies aimed at obtaining maximum effectiveness from the various components used for their preparation in order to accentuate the desired effects without causing negative side effects of any kind. It should in fact be considered that most of the supplements are made up of components of natural origin whose properties, although documented, would often be insufficient to obtain sensitive and lasting effects if these products were taken alone. It should also be remembered that the final effect can be achieved in various ways, that is by using active ingredients, natural or synthetic, which perform different actions (antioxidants, activity on the cell membrane, on the capillary walls, anti-cholesterol, antiplatelet agent, etc.) and that they interact with each other in a more or less synergistic way so the final effect depends in a decisive way on the type of components that are mixed.
E’ poi indispensabile considerare, I fine di ottenere un prodotto utile, che l’attività dei vari componenti degli integratori può risentire notevolmente della forma di somministrazione del prodotto (sciroppi, soluzioni, bustine idrosolubili, compresse, tavolette ecc.) e, d’altra parte, è importante che il preparato possa svolgere la sua azione quando assunto in modo facile da parte del fruitore in modo da renderne agevole l’uso in qualsiasi situazione. It is then essential to consider, in order to obtain a useful product, that the activity of the various components of the supplements can be significantly affected by the form of administration of the product (syrups, solutions, water-soluble sachets, tablets, tablets etc.) and, of on the other hand, it is important that the preparation can perform its action when taken easily by the user in order to make it easy to use in any situation.
Descrizione dettagliata dell'invenzione Detailed description of the invention
La presente invenzione si riferisce ad un integratore dietetico mirato al miglioramento e/o ripristino delle capacità mnemoniche del soggetto mentalmente affaticato, grazie ad un miglioramento fisiologico e circolatorio dovuto all’effetto sinergico sviluppato dai particolari componenti dei prodotto stesso. The present invention refers to a dietary supplement aimed at improving and / or restoring the mnemonic abilities of the mentally fatigued subject, thanks to a physiological and circulatory improvement due to the synergistic effect developed by the particular components of the product itself.
Inoltre il prodotto secondo l'invenzione presenta l’ulteriore vantaggio di poter essere somministrato in forma di tavolette masticabili e/o solubili nel cavo orale o di compresse, rendendone quindi estremamente agevole l’uso da parte degli utilizzatori. Furthermore, the product according to the invention has the further advantage of being able to be administered in the form of chewable and / or oral-soluble tablets or tablets, thus making it extremely easy to use by users.
L’integratore dietetico secondo l'invenzione comprende un complesso fosfolipidico vegetale naturale arricchito con tecnica assolutamente naturale (quindi non proveniente da polialcooli), in combinazione con estratto secco di mirtillo, Ginko biloba e L-acetilcamitina. The dietary supplement according to the invention comprises a natural vegetable phospholipid complex enriched with an absolutely natural technique (therefore not coming from polyalcohols), in combination with dry extract of blueberry, Ginko biloba and L-acetylcamitine.
Per “complesso fosfolipidico vegetale naturale arricchito” si intende, secondo l'invenzione, lecitina di soia altamente purificata ad alta concentrazione di fosfatidilserina e comprendente anche fosfatidiletanolammina, fosfatidilcolina e fosfatidilinositolo; detti componenti essendo presenti nel complesso secondo l’invenzione in quantità rispettivamente comprese fra 18-24%, 20-12%, 18-13% e 7-12% in peso. According to the invention, the term "enriched natural vegetable phospholipid complex" means highly purified soy lecithin with a high concentration of phosphatidylserine and also including phosphatidylethanolamine, phosphatidylcholine and phosphatidylinositol; said components being present in the complex according to the invention in quantities respectively comprised between 18-24%, 20-12%, 18-13% and 7-12% by weight.
Preferibilmente i singoli elementi suddetti sono presenti nel complesso rispettivamente nelle seguenti quantità 22%, 18%, 15% 10% (valori medi). Preferably, the aforesaid individual elements are present as a whole in the following amounts respectively 22%, 18%, 15% 10% (average values).
Il complesso fosfolipidico costituisce il 40 - 15% iri peso calcolato sul totale di integratore dietetico, preferibilmente il 19%. The phospholipid complex constitutes 40-15% by weight calculated on the total dietary supplement, preferably 19%.
L'estratto secco di mirtillo è compreso fra 5 e 15% in peso calcolato sul totale di integratore dietetico, in particolare il 10%. The dry extract of blueberry is between 5 and 15% by weight calculated on the total dietary supplement, in particular 10%.
La L-acetilcarnitina costituisce il 15 - 20% in peso calcolato sul totale di integratore, preferibilmente il 8 - 12%. L-acetylcarnitine constitutes 15 - 20% by weight calculated on the total supplement, preferably 8 - 12%.
Per estratto di Ginko biloba si intende Γ estratto di foglie dell’albero Ginko biloba al 24% di glicosidi ginkoflavonici ed altri componenti utili (ginkgolidi e bilobalidi). By Ginko biloba extract we mean Γ extract of the leaves of the Ginko biloba tree with 24% of ginkoflavonic glycosides and other useful components (ginkgolides and bilobalides).
L’estratto di Ginko biloba, essenziale in quanto svolge una particolare azione anticolesterolo ed antiaggregante, è compreso fra 2 e 6% in particolare 4 % in peso calcolato sul totale di integratore dietetico. Ginko biloba extract, essential as it has a particular anti-cholesterol and anti-aggregating action, is between 2 and 6% in particular 4% by weight calculated on the total dietary supplement.
Oltre ai componenti suddetti l’integratore dietetico secondo l’invenzione potrà contenere: acido glutammico, vitamine (come C, E, Β,, Be, B1Z), minerali (ad esempio potassio, magnesio, fosforo, selenio), leganti (come fibre di lecitina di soia, fibre naturali, amidi, lattosio, latte in polvere) e le usuali essenze, aromi o sostanze naturali utilizzate per questo tipo di prodotti. In addition to the aforementioned components, the dietary supplement according to the invention may contain: glutamic acid, vitamins (such as C, E, Β ,, Be, B1Z), minerals (for example potassium, magnesium, phosphorus, selenium), binders (such as fibers of soy lecithin, natural fibers, starches, lactose, milk powder) and the usual essences, flavors or natural substances used for this type of products.
I componenti l’integratore dietetico potranno essere facilmente manipolati secondo le usuali tecniche della farmacopea a costituire tavolette o compresse , normalmente del peso di circa 0,5 - 2,5 g. The components of the dietary supplement can be easily manipulated according to the usual techniques of the pharmacopoeia to form tablets or tablets, normally weighing about 0.5 - 2.5 g.
Un esempio particolare e non limitativo di integratore dietetico secondo l’invenzione è riportato qui di seguito. A particular and non-limiting example of a dietary supplement according to the invention is shown below.
Complesso fosfolipidico vegetale mg 190 [di cui fosfatidilserina 22%, fosfatidiletanolammina 18%, fosfatidiicolina 15%, fosfatidilinositolo 10% (valori medi)] Vegetable phospholipid complex mg 190 [of which phosphatidylserine 22%, phosphatidylethanolamine 18%, phosphatidiicoline 15%, phosphatidylinositol 10% (average values)]
Ac. Glutammico mg. 180 B.C. Glutamic mg. 180
L-acetilcarnitina mg. 100 L-acetylcarnitine mg. 100
Estratto di mirtillo secco mg. 100 Dry blueberry extract mg. 100
Ginko biloba mg. 40 Ginko biloba mg. 40
Ac. Linoleico mg. 37 B.C. Linoleic mg. 37
Vitamina C mg. 60 Vitamin C mg. 60
Vitamina E mg 10 Vitamin E 10 mg
Vitamina B , mg. 1 ,4 Vitamin B, mg. 1, 4
Vitamina B6 mg. 1 ,4 Vitamin B6 mg. 1, 4
Vitamina B12 mcg. 0,6 Vitamin B12 mcg. 0.6
Potassio mg. 100 Potassium mg. 100
Magnesio mg. 40 Magnesium mg. 40
Fosforo mg. 2,56 Phosphorus mg. 2.56
Selenio mcg.40 Selenium mcg. 40
Eccipienti ed aromi o sostanze naturali q.b. a 1 ,5 g. Excipients and flavors or natural substances to taste at 1, 5 g.
Grazie al sinergismo di azione fra i suoi vari componenti, l’integratore dietetico secondo l’invenzione può intervenire favorevolmente negli stati di stanchezza cerebrale, carenza di concentrazione, affaticamento visivo e mentale, nel miglioramento della circolazione sanguigna e del livello di colesterolo e, più in generale, come apportatore di energia negli stati di stress psico-fisico. Thanks to the synergy of action between its various components, the dietary supplement according to the invention can favorably intervene in states of brain fatigue, lack of concentration, visual and mental fatigue, in improving blood circulation and cholesterol level and, more in general, as an energy supplier in states of psycho-physical stress.
Normalmente la somministrazione è di 1 tavoletta una volta al dì o di una compressa 2 volte al dì. Normally the administration is 1 tablet once a day or one tablet 2 times a day.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000TO000172A ITTO20000172A1 (en) | 2000-02-23 | 2000-02-23 | PHYTOBIOLOGICAL DIETARY SUPPLEMENT. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000TO000172A ITTO20000172A1 (en) | 2000-02-23 | 2000-02-23 | PHYTOBIOLOGICAL DIETARY SUPPLEMENT. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITTO20000172A0 ITTO20000172A0 (en) | 2000-02-23 |
ITTO20000172A1 true ITTO20000172A1 (en) | 2001-08-23 |
Family
ID=11457469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2000TO000172A ITTO20000172A1 (en) | 2000-02-23 | 2000-02-23 | PHYTOBIOLOGICAL DIETARY SUPPLEMENT. |
Country Status (1)
Country | Link |
---|---|
IT (1) | ITTO20000172A1 (en) |
-
2000
- 2000-02-23 IT IT2000TO000172A patent/ITTO20000172A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ITTO20000172A0 (en) | 2000-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9220741B2 (en) | Weight loss formulation | |
US20210299205A1 (en) | Water soluble tomato extract protects against adverse effects of air pollution | |
CA2564326A1 (en) | Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite | |
JP5775668B2 (en) | Anti-fatigue agent containing amino acid composition | |
RU2013135311A (en) | COMBINATION OF COMPONENTS FOR PREVENTION AND TREATMENT OF DISABILITIES | |
ITMI20071214A1 (en) | COMPOSITIONS BASED ON PREBIOTIC AND IMMUNOGENIC COMPONENTS FOR THE PREVENTION AND TREATMENT OF GASTROENTERIC DISORDERS FROM DISBIOSIS AND / OR ALTERATIONS OF THE NORMAL INTESTINAL FLORA | |
ITRM980636A1 (en) | USE OF CARNITINE AND RESVERATROL TO PRODUCE A COMPOSITION FOR THE PREVENTION OR THERAPEUTIC TREATMENT OF BRAIN ALTERATIONS CAUSED BY AGING AND NEUROTOXIC DRUGS. | |
WO2007063158A2 (en) | Functional food having positive effects in the prevention of cardiovascular diseases | |
Sharma et al. | Non-pharmacological treatments for ADHD in youth | |
DE102007022694A1 (en) | Milk fat milk protein composition to improve calcium absorption | |
CN102406126A (en) | Red starter fermented highland barley chewable tablets and preparation method thereof | |
CN107427485B (en) | Medium chain fatty acids and triglycerides thereof for the treatment of anxiety disorders | |
DE102014100534A1 (en) | Powdered composition for the manufacture of a food substitute | |
BR102012021282A2 (en) | chia seed energy drink composition | |
CA2821219A1 (en) | Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof | |
ITTO20000172A1 (en) | PHYTOBIOLOGICAL DIETARY SUPPLEMENT. | |
ITTO20080532A1 (en) | DIETARY SUPPLEMENT FOR NEURONAL AND SENSORY ENHANCEMENT | |
US20180228855A1 (en) | Compositions and methods for enhancing working and long-term memory support using new combination of ginkgo biloba and panax ginseng and associated components | |
CH661443A5 (en) | Pharmaceutical compositions having metabolic activity | |
GR1010228B (en) | Orally-administrated nutrition supplement of vitamins, minerals, natural extracts and probiotics for boositng the immune system | |
CN108095067A (en) | A kind of preparation method alleviated visual fatigue and enhance memory capsule | |
CA2751218A1 (en) | Weight loss formulation | |
Nasri | Impact of vitamin C on parathormone secretion in patients on hemodialysis with secondary hyperparathyroidism | |
EA017041B1 (en) | Multivitamin composition | |
RU145631U1 (en) | ADDITION DIET "TEA FROM AROMATIC HERBS OF THE NIKITA GARDEN SERIES" |